Jipmer enrolls first infant in NeoSep1 international clinical trial in fight against neonatal sepsis

AI Summary

Jipmer hospital in India has enrolled its first infant in NeoSep1, a global clinical trial targeting neonatal sepsis. This marks India's entry into international efforts to combat this serious infection in newborns.

The enrolment of the first infant at Jipmer marks the beginning of India’s participation in the global clinical trials dedicated exclusively to neonatal sepsis, according to the institute